Mergers & Acquisitions

The Life Sciences Division directors hold strong global relationships across the life sciences and financial industries –built on trust, integrity and intended to endure the cyclical investment cycle, with confidence. With six degrees dynamic relationships with stakeholders across the full eco-system and value chain of the life sciences sector we hold deep, real-time insight and market knowledge.

The Life Sciences Division investment banking distribution actively seeks to improve pricing and efficient capital markets revealing true value of life science companies that otherwise might fall prey to opportunistic buyers.  Our research services provide access to and drive engagement with new investors and industry partners, more efficiently enabling us to facilitate corporate growth, be that organic, bolt on acquisitions, licensing or alternative corporate financial strategies.

M&A deal making is a core competency at The Life Sciences Division, working in a strategic way to help corporate clients achieve goals, always in an integrated way across corporate broking and advisory. M&A strategy includes generating synergies or improving operational performance to have a focussed business delivering success. The team have previously worked on major transformational projects to create value, are adept in mergers, acquisitions, divestments, licensing and co-creation. We have a track record of global cross border deal making.